Improvement in overall survival with carfilzomib, lenalidomide, and dexamethasone in patients with relapsed or refractory multiple myeloma

  1. Siegel, D.S.
  2. Dimopoulos, M.A.
  3. Ludwig, H.
  4. Facon, T.
  5. Goldschmidt, H.
  6. Jakubowiak, A.
  7. San-Miguel, J.
  8. Obreja, M.
  9. Blaedel, J.
  10. Stewart, A.K.
Aldizkaria:
Journal of Clinical Oncology

ISSN: 1527-7755 0732-183X

Argitalpen urtea: 2018

Alea: 36

Zenbakia: 8

Orrialdeak: 728-734

Mota: Artikulua

DOI: 10.1200/JCO.2017.76.5032 GOOGLE SCHOLAR

Garapen Iraunkorreko Helburuak